These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 6334720

  • 1. Immunomodulation and antitumor effects of MVE-2 in mice.
    Talmadge JE, Maluish AE, Collins M, Schneider M, Herberman RB, Oldham RK, Wiltrout RH.
    J Biol Response Mod; 1984 Dec; 3(6):634-52. PubMed ID: 6334720
    [Abstract] [Full Text] [Related]

  • 2. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
    Schultz RM, Tang JC, DeLong DC, Ades EW, Altom MG.
    Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
    [Abstract] [Full Text] [Related]

  • 3. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
    Wiltrout RH, Herberman RB, Zhang SR, Chirigos MA, Ortaldo JR, Green KM, Talmadge JE.
    J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
    [Abstract] [Full Text] [Related]

  • 4. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
    Schlick E, Ruffmann R, Chirigos MA, Welker RD, Herberman RB.
    Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661
    [Abstract] [Full Text] [Related]

  • 5. Maleic vinyl ether activation of murine macrophages against lung-metastasizing tumors.
    Loveless SE, Munson AE.
    Cancer Res; 1981 Oct; 41(10):3901-6. PubMed ID: 7285000
    [Abstract] [Full Text] [Related]

  • 6. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
    Milas L, Hersh EM, Hunter N.
    Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
    [Abstract] [Full Text] [Related]

  • 7. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow.
    Wiltrout RH, Pilaro AM, Gruys ME, Talmadge JE, Longo DL, Ortaldo JR, Reynolds CW.
    J Immunol; 1989 Jul 01; 143(1):372-8. PubMed ID: 2732472
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant chemoimmunotherapy of cancer: influence of tumor burden and role of functional immune effector cells in mice.
    Schlick E, Hewetson P, Ruffmann R.
    Cancer Res; 1986 Jul 01; 46(7):3378-83. PubMed ID: 3708572
    [Abstract] [Full Text] [Related]

  • 9. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
    Rao VS, Mitchell MS.
    J Biol Response Mod; 1983 Jul 01; 2(1):67-80. PubMed ID: 6606020
    [Abstract] [Full Text] [Related]

  • 10. Regulation of natural killer cell activation: implementation for the control of tumor metastasis.
    Hanna N.
    Nat Immun Cell Growth Regul; 1983 Jul 01; 3(1):22-33. PubMed ID: 6235447
    [Abstract] [Full Text] [Related]

  • 11. Immunomodulatory effect of various molecular-weight maleic anhydride-divinyl ethers and other agents in vivo.
    Chirigos MA, Stylos WA.
    Cancer Res; 1980 Jun 01; 40(6):1967-72. PubMed ID: 7371032
    [Abstract] [Full Text] [Related]

  • 12. Biological response modifiers: regulators of the cellular immune system and adjuvants in antitumor therapy.
    Chirigos MA, Schlick E, Saito T, Gruys E.
    Methods Find Exp Clin Pharmacol; 1986 Jan 01; 8(1):27-33. PubMed ID: 3486334
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Response of murine leukemia to combined BCNU-maleic anhydride-vinyl ether (MVE) adjuvant therapy and correlation with macrophage activation by MVE in the in vitro growth inhibition assay.
    Dean JH, Padarathsingh ML, Keys L.
    Cancer Treat Rep; 1978 Nov 01; 62(11):1807-16. PubMed ID: 728898
    [No Abstract] [Full Text] [Related]

  • 19. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 20. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F, Peri G, Villa A, Mantovani A.
    J Immunol; 1984 Feb 01; 132(2):936-44. PubMed ID: 6690624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.